1,378 total results
Comment
The Memorial Sloan-Kettering website mentions that 177Lu-PSMA-617 was FDA-approved in March 2022.
Discussion
How long after EBRT does the PSA bounce around?
Hello from Vancouver Island. I had a prostatectomy about three years ago and the PSA went down from 4.0 to about 0.03 after surgery. Within...
Discussion
Biopsy results benign. PSA is elevated. What is the next step?
I posted earlier though I can't find my thread. Here is my data: "I was tested with PSA 5.3 on November 2023, and 3T MRI...
Discussion
Treatment options for locally advanced prostate cancer?
I have recently been diagnosed with locally advanced prostate cancer in December 2023. I had an MRI that diagnosed my PC with a Gleason 9...
Discussion
RT + 3 years ADT + 2 years Zytiga initial treatment?
Is anyone here being treated for non-metastatic disease with 3 years ADT + 2 years abiraterone (e.g. Zytiga) as a first Hormone treatment? I'd be...
Discussion
Low dose brachytherapy long term side effect risk
My 55 year old husband has Gleason 7 (4+3) posterior peripheral T2a prostate carcinoma with PSA 5.2. 1 ml more or less volume tumour. PSMA...
Discussion
Husband's prostate cancer story
My 64 yr old husband was having urination frequency and enlarged prostrate. Visited the urologist for at least two years. His PSA was around 4,...
Discussion
Patient movement during proton therapy more problematic than photon?
I am now 68 yrs old. My PSA level went beyond normal range in 2023 with a PSA of 4.3. Saw a urologist and had...
Discussion
Tulsa Pro - my initial treatment experience
I want to thank all for support on my recent prostate cancer treatment, Tulsa pro. I am very thankful to my wife and my daughter...
Discussion
How will I know EBRT has worked?
I'm writing to share with you my journey with Prostate Cancer. I am 73 years old, from Calcutta, India and getting treated at Tata Medical...
Discussion
Seminal Vesicle Invasion & PR22/MIDS/SPORT Trials ADT & ART
Hello all, Thanks for reading. My father is 63 close to 64. He was diagnosed with prostate cancer (acinar adenocarcinoma) late last year 2022. We...